Preeclampsia and aspirin
Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities. Aspirin is a non-selective non-st...
Main Authors: | Tae Gyu Ahn, Jong Yun Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology
2023-05-01
|
Series: | Obstetrics & Gynecology Science |
Subjects: | |
Online Access: | http://ogscience.org/upload/pdf/ogs-22261.pdf |
Similar Items
-
Comparison of the efficacy of 75 mg aspirin versus 150 mg aspirin for prevention of preeclampsia in patients at high risk for preeclampsia
by: Dr. Natasha Bushra, et al.
Published: (2024-03-01) -
Association between Serum HLA-G Levels in The First Trimester of Pregnancy and The Onset of Preeclampsia: A Systematic Review and Meta-analysis Study
by: Salome Maghsudlu, et al.
Published: (2023-10-01) -
Hydatidiform molar pregnancy presenting with preeclampsia in 6th weeks of pregnancy: a case report
by: Laya Shirinzadeh, et al.
Published: (2018-09-01) -
TRIAL OF ASPIRIN AND CALCIUM ON PREVENTION OF PREECLAMPSIA
by: ALI AKBA TAHERIAN, et al.
Published: (2002-06-01) -
Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester
by: Piotr Tousty, et al.
Published: (2023-05-01)